Skip to main content

New and competing renewal awards for August 2020

Sunday, September 20, 2020
McGovern Davison Children's Health Center

The following are new and competing renewal awards made to faculty in the Department of Pediatrics through the month of August 2020.  Please extend your congratulations to the following individuals.

Sarah Armstrong, MD (Primary Care) and Ashley Skinner, PhD (Population Health Sciences), received an award from the National Institutes of Health/NICHD in the amount of $3,157,618 for a project entitled Parks and Pediatrics Fit Together: Translating Knowledge into Action for Child Obesity Treatment in Partnership with Parks and Recreation. The project period is 08/19/2020-06/30/2025.

Karl Dimiter-Bissig, MD, PhD (Medical Genetics), received an award from Baylor College of Medicine in the amount of $108,914 for a project entitled Physiological Dissection of the Mevalonate Pathway. The project period is 04/072020-02/28/2021.  

Areeg El-Gharbawy, MBBCh, MD (Medical Genetics), received an award from Idorisa Pharmaceuticals in the amount of $65,560 for a project entitled A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Determine the Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects with Fabry Disease. The project period is 08/06/2020-09/09/2021.

Michael Freemark, MD (Endocrinology), received an award from Rhythm Pharmaceuticals in the amount of $99,702 for a project entitled Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated with Genetic Defects Upstream of the MC4 Recepto. The project period is 7/28/2020-07/31/2025.

Rasheed Gbadegesin, MD, MBBS (Nephrology), received an award from Reata Pharmaceuticals in the amount of $100,496 for a project entitled An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in patients with Chronic Kidney Disease. The project period is 08/05/2020-08/04/2022.

Andrew Landstrom, MD, PhD, (Cardiology), received an award from The Doris Duke Charitable Foundation, Inc. in the amount of $495,000 for a project entitled Targeting Wnt- Signaling to Prevent Sudden Death in Pediatric Arrhythmic Cardiomyopathy TBD. The project period is 09/01/2020-08/31/2023. 

Corinne Linardic, MD, PhD, (Hematology-Oncology), received a supplemental award from the National Institutes of Health/NCI in the amount of $38,133 for a project entitled Creating a TurboID-PAX3-FOXO1 Knock-in Mouse to Identify the Vivo Interactome of the Fusion Oncoprotein PAX-FOXO1. The project period is 08/11/2020-08/31/2024.

M. Anthony Moody, MD, (Infectious Diseases), received an award from Research Triangle Institute/NIH in the amount of $216,754 for a project entitled Emerging Infectious Diseases-Coordination Center. The project period is 03/01/2020-02/28/20205.

Sallie Permar, MD, PhD (Infectious Diseases), received a supplemental award from the National Institutes of Health in the amount of $1,527,165 for a project entitled Immunogenicity and Efficacy of SARS-CoV-2 Stabilized Perfusion Spike Protein Vaccines in infant Rhesus Macaques. The project period is 06/01/2020-03/31/2021.

Emmanuel Walter, MD, MPH (Infectious Diseases), received an award from Fred Hutchinson/NIH in the amount of $378,710 for a project entitled COVID-19 Prevention Network (CoVPN) Site Preparation. The project period is 06/01/2020-11/30/2020.

Muhammad Zafar, MBBS (Neurology), received an award from Marinus Pharmaceuticals in the amount of $79,166 for a project entitled A Phase 2 Open-label 12-Week Trial of Adjunctive Ganaxolone Treatment (Part A) in Tuberous Sclerosis Complex-related Epilepsy followed by Long-term Treatment (Part B). The project period is 07/20/2020-07/19/2023.

Congratulations to these faculty on their awards and best wishes to them in their investigative work.

Coleen K. Cunningham, MD
Vice Chair, Research
Professor of Pediatrics
Division of Infectious Diseases
Chief, Division of Global Health